Atlas Trials

Drug-Drug Interaction (DDI) Study for TQB3616

Clinical trial NCT06662773 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06662773
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2024-11-01
Primary completion
2025-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.